Arronax Nantes > Expérimentation préclinique et recherche clinique > Nos Publications > 2022 > Publication 2022 3
Publication 2022 3
Prognostic value of FDG-PET/CT response for patient selection before chimeric antigen receptor-T-cells therapy in non-Hodgkin lymphoma, Bailly, C ; Carlier, T ; Tessoulin, B ; Gastinne, T ; Kraeber-Bodere, F ; Le Gouill, S & al , Hematol Oncol, 2022, 40, 796-800
https://doi.org/10.1002/hon.2965